Author： Mansi Ishak
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.12, Iss.3, 2013-05, pp. : 327-337
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Considerable reductions in US coronary deaths - why?
Inpharma, Vol. 1, Iss. 1592, 2007-01 ,pp. :
Access to resources
Recommend
Does `NICE blight' exist, and if so, why?
By Haycox Alan
PharmacoEconomics, Vol. 26, Iss. 12, 2008-01 ,pp. :
Is statin therapy a waste of resources?
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
Is statin therapy a waste of resources?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 346, 2002-01 ,pp. :
Is early statin initiation after ACS beneficial?
Inpharma, Vol. 1, Iss. 1344, 2002-01 ,pp. :